Author:Ilaria De Giovanni

News, Rare diseases

Sciensus partners with Sentynl Therapeutics

Thought Leadership, Rare diseases

Launching successful patient support programs for rare disease patients across Europe

Blogs/Articles, Rare diseases

Orphan drugs: How to avoid costly stock losses in Europe 

Blogs/Articles, Rare diseases

Out-licensing vs partnering: Strategies for accessing Europe 

Blogs/Articles, Rare diseases

Is data drought holding back your orphan drug?

Thought Leadership, Rare diseases

Market access for orphan drugs in Switzerland: a guide for Biotechs

Thought Leadership, Cancer

The benefits of digitally collecting PROMs to study patient wellbeing.

Blogs/Articles, Rare diseases

An introduction to PASS studies